Objective-Angiotensin II (Ang II) infusion causes aortic medial thickening via stimulation of angiotensin II type 1a (AT1a) receptors. The purpose of this study was to determine the cellular loci of AT1a receptors that mediate this Ang II-induced aortic pathology. Approach and Results-Saline or Ang II was infused into AT1a receptor floxed mice expressing Cre under control of cellspecific promoters. Initially, AT1a receptors were depleted in aortic smooth muscle cell and endothelium by expressing Cre under control of SM22 and Tie2 promoters, respectively. Deletion of AT1a receptors in either cell type had no effect on Ang II-induced medial thickening. To determine whether this effect was related to neural stimulation, AT1a receptors were depleted using an enolase 2-driven Cre. Depletion of AT1a receptors in neural cells attenuated Ang II-induced medial thickening of the ascending, but not descending aorta. Lineage tracking studies, using ROSA26-LacZ, demonstrated that enolase 2 was also expressed in adventitial cells adjacent to the region of attenuated thickening. To determine whether adventitial fibroblasts contributed to this attenuation, AT1a receptors in fibroblasts were depleted using S100A4 driven Cre. Similar to enolase 2-Cre, Ang II-induced medial thickening was attenuated in the ascending, but not the descending aorta. Lineage tracking demonstrated an increase of S100A4-LacZ positive cells in the media of the ascending region during Ang II infusion. Conclusions-AT1a receptor depletion in fibroblasts attenuates Ang II-induced medial hyperplasia in the ascending aorta.
A ngiotensin II (Ang II) infusion into rodents promotes aortic pathology including pronounced medial thickening that has been attributed to smooth muscle cell (SMC) hypertrophy and hyperplasia. [1] [2] [3] Ang II infusion promotes a uniform degree of medial thickening throughout the aorta because of region-specific mechanisms, with hyperplasia in the ascending aorta and hypertrophy in the rest of the aorta. 3 Although Ang II infusion increases blood pressure, equivalent increases during norephinephrine infusion does not cause medial thickening. This is consistent with Ang II-induced arterial medial thickening being independent of blood pressure in mice. 3, 4 Both pharmacological and genetic manipulations have demonstrated that Ang II-induced medial thickening is attributable to stimulation of angiotensin II type 1 (AT1) receptors, or AT1a receptors in rodents. 3, 5 The role of AT1 receptors in promoting medial thickening has been inferred from cell culture studies that have demonstrated Ang II promotes SMC hypertrophy and hyperplasia. [6] [7] [8] Ang II-induced aortic medial thickening is inhibited by coadministration of losartan to antagonize AT1 receptors. 9 Furthermore, AT1a receptor deletion prevents Ang II-induced medial expansion in mice. 3 Deletion of AT1b receptors had no effect on aortic changes during Ang II infusion, despite its mediation of aortic contractile responses. 10, 11 Although there has been uniformity in defining AT1a receptors as regulators of Ang II-induced aortic changes in vivo, the cellular loci of this effect has not been determined. Development of AT1a receptor floxed mice provides an approach to examine cell-specific effects of Ang II stimulation. 12, 13 Because medial thickening is entirely attributable to hypertrophic and hyperplastic responses in SMCs, this seems the most likely effector cell during Ang II infusion.
However, AT1a receptor deletion in a SMC-specific manner had no effect on aortic medial expansion. 5 Therefore, the cell type activated by Ang II to promote aortic thickening remains unknown. This study initially determined the effects of AT1a receptor deletion in SMCs and confirmed a previous study in finding no effect on Ang II-induced aortic medial thickening. 5 Subsequently, we examined a series of cell types to identify those responsible for Ang II-induced medial expansion. These studies identified AT1a receptor stimulation on fibroblasts as the basis for Ang II-induced aortic medial expansion in the ascending region.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

SMC-Specific AT1a Receptor Deficiency Had No Effect on Ang II-Induced Hypertension and Aortic Medial Thickening
Because medial thickening is attributable to vascular SMC proliferation, this cell type is an obvious potential target for Ang II. First, we generated mice with AT1a receptor deletion in SMCs by expressing Cre under control of the SM22 promoter. Deletion of AT1a receptor expression was validated by mRNA abundance as described previously. 12 Male nontransgenic littermates (SM22-Cre 0/0) were used as wildtype controls. Both SM22-Cre 0/0 and SMC-specific AT1a receptor-deficient (SM22-Cre +/0) mice were infused with either saline or Ang II for 28 days. SMC-specific deletion of AT1a receptors did not affect body weight during Ang II infusion ( Table I in the online-only Data Supplement). To examine the role of SMC-specific AT1a receptor deficiency in blood pressure responsiveness to Ang II, we measured systolic blood pressure before and during the last week of Ang II infusion. SMC-specific AT1a receptor deficiency had no effect on systolic blood pressure during Ang II infusion ( Table I in the online-only Data Supplement), in agreement with other studies. 5 To quantify Ang II-induced vascular changes, medial thickness and area were measured by morphometric analysis in the ascending and descending aorta. Medial thickness and area significantly increased in mice infused with Ang II compared with saline groups in both ascending and descending regions (P<0.05; Figure 1A and 1B; Table II in the onlineonly Data Supplement). However, medial thickness in both ascending and descending aortic regions were not different between SM22-Cre 0/0 and SM22-Cre +/0 mice infused with Ang II ( Figure 1A and 1B; Table II in the online-only Data Supplement). Medial areas in both aortic regions were also similar between Ang II groups ( Table I in the online-only Data Supplement), demonstrating that deficiency of AT1a receptors in SMCs had no effect on Ang II-induced medial thickening in either the ascending or descending aorta.
Endothelial Cell-Specific AT1a Receptor Deficiency Had No Effect on Ang II-Induced Hypertension and Aortic Medial Thickening
Endothelial cells also represent a potential target because this cell type is juxapositioned to the aortic medial layer and secretes bioactive substances that influence SMC function. We generated endothelial cell-specific AT1a receptor-deficient mice by breeding AT1a receptor floxed mice to mice expressing Cre controlled by the Tie2 promoter. Validation of receptor deletion was described previously. 12 Similar to SMCs, male nontransgenic littermates (Tie2-Cre 0/0) were compared with endothelial cell-specific AT1a receptor-deficient (Tie2-Cre +/0) mice and infused with either saline or Ang II for 28 days. Endothelial cell-specific AT1a receptor deficiency had no effect on body weight or blood pressure during Ang II infusion ( Table I in Medial thickness and area of ascending and descending aortas were measured to determine the role of endothelial cells in Ang II-induced vascular pathology. As expected, medial thickness and medial area significantly increased in mice infused with Ang II compared with saline in both ascending and descending regions of aortas (P<0.05; Figure 2A 
Neuronal-Specific AT1a Receptor Deficiency Had No Effect on Ang II-Induced Blood Pressure Changes, But Decreased Medial Hyperplasia in the Ascending Aorta
To assess whether Ang II stimulates a neuronal response that would promote medial changes, AT1a receptor floxed mice were bred to mice expressing Cre driven by the enolase 2 (Eno2) promoter. AT1a receptor-deficient mice with Cre expression driven by the Eno2 promoter (Eno2-Cre +/0) were compared with male nontransgenic littermates (Eno2-Cre 0/0). These mice were infused with either saline or Ang II for 28 days. AT1a receptor depletion was validated by demonstrating a decrease of mRNA abundance of the AT1a receptor in the brain of Eno2-Cre +/0 mice compared with nontransgenic littermates ( Figure IA in the online-only Data Supplement). There were no differences in body weight among all the study groups. Eno2-Cre +/0 and Eno2-Cre 0/0 mice had similar increases of blood pressure in response to Ang II infusion ( Table IV in the online-only Data Supplement).
We measured aortic medial thickness to determine the effects of neuronal deletion of AT1a receptors during Ang II infusion. As expected, there was a significant increase in medial thickness and area in mice infused with Ang II compared with saline groups in Eno2-Cre 0/0 mice (P<0.05; Figure 3A and 3B; Tables IV and V in the online-only Data Supplement). Interestingly, there was a significant decrease in medial thickness in AT1a receptor depletion in Eno2-Cre +/0 compared with Eno2-Cre 0/0 mice in the ascending aorta with Ang II infusion (P<0.05; Figure 3A ). However, this reduction was not observed in the descending aorta during Ang II infusion ( Figure 3B) .
Ang II-induced medial thickening is attributable to an increase in space between intralaminar layers of the aorta. 3 Our previous studies have demonstrated that Ang II-induced aortic medial expansion in the ascending aorta was because of hyperplasia. 3 Therefore, we compared ascending and descending aortic tissue sections stained with propidium iodide. 3 We found no difference in nuclei numbers in either ascending and descending aortas of saline-infused mice between genotypes ( Figures 3C and 3D ). However, Ang II infusion into Eno2-Cre +/0 mice significantly decreased number of nuclei compared with Eno2-Cre 0/0 mice (P<0.05; Figures 3C) in the ascending aorta. Therefore, these results demonstrated that AT1a receptor deficiency under control of the Eno2 promoter attenuated Ang II-induced medial hyperplasia in the ascending aorta.
Many cell-specific promoters have promiscuous expression that lead to broader expression than defined by their nomenclature. 14 To determine the specificity of the Eno2driven Cre, we bred these transgenic mice to ROSA26-lacZ reporter mice. Whole brain tissue mounts showed presence of β-galactosidase (β-gal) activity in Eno2-Cre +/0 mice, whereas no positive activity was detected in nontransgenic littermates ( Figure IB in the online-only Data Supplement). Interestingly, we also found β-gal activity restricted to the ascending aorta, with no expression in the descending aorta in Eno2-Cre expressing mice ( Figure IC in the online-only Data Supplement). Furthermore, to determine expression of Eno2-lacZ in the aorta, we serially sectioned the ascending aorta and found that β-gal staining colocalized with reticular fibroblast immunostaining, but not with α-actin, a smooth muscle marker ( Figure 3F ). Our results delineated that in addition to neuronal tissues, Eno2 promoter-driven Cre led to depletion of floxed genes in the adventitia of the ascending aorta.
Fibroblast Cell-Specific AT1a Receptor Deficiency Had No Effect on Ang II-Induced Blood Pressure But Attenuated Medial Hyperplasia in the Ascending Aorta
To define the role of fibroblasts, we generated fibroblast cell-specific AT1a receptor-deficient mice by breeding AT1a receptor floxed mice to mice with the Cre transgene under control of the S100A4 promoter. Depletion of AT1a receptors was validated with significant reduction of receptor mRNA abundance in aortic adventitia in AT1a receptor cell-specific deficient mice (S100A4-Cre +/0) compared with nontransgenic littermates (S100A4-Cre 0/0; P<0.05; Figure 4A ). Male S100A4-Cre 0/0 and S100A4-Cre +/0 mice were infused with either saline or Ang II for 28 days. Genotype and infusion had no effect on body weight. Blood pressure increased during Ang II infusion to a similar rate in the 2 genotypes (Table VI  in Medial thickness and area were measured in S100A4-Cre 0/0 and S100A4-Cre +/0 mice infused with either saline or Ang II for 28 days. Consistent with both the groups used in this study, Ang II increased medial thickness and area (P<0.05; Figure 4B and 4C; Tables VI and VII in the onlineonly Data Supplement). However, Ang II-infused S100A4-Cre +/0 mice had significantly decreased medial thickness compared with S100A4-Cre 0/0 mice in the ascending aorta (P<0.05; Figure 4B ). In contrast, medial thickness or area were not different in descending aortas between the 2 genotypes infused with Ang II (Figure 4C ; Tables VI and VII in the online-only Data Supplement). Our results demonstrate that fibroblast cell-specific AT1a receptor deficiency attenuated Ang II-induced medial thickening in the ascending aorta.
In a subsequent study, ascending and descending aortic regions of S100AA4-Cre 0/0 and +/0 mice infused with either saline or Ang II were stained with propidium iodide. There was no difference in nuclei counts in ascending and descending aortas of saline-infused mice ( Figure 4D and 4E ). However, AT1a receptor S100A4-Cre +/0 aortas had fewer number of nuclei compared with 0/0 ascending aortas during Ang II infusion (P<0.05; Figure 4D and 4F). In contrast, there was no change in nuclei counts of descending aortas after Ang II infusion between the 2 genotypes ( Figure 4E and 4F) . Therefore, deficiency of AT1a receptor under control of the S100A4 promoter attenuated Ang II-induced medial hyperplasia in the ascending aorta.
Presence of Lineage-Tracked S100A4 Positive Cells in Adventitial and Medial Layers of the Ascending Aorta
Because AT1a receptor deficiency driven by the S100A4 promoter is involved in medial hyperplasia, we examined cell lineage tracking of S100A4 in aortic tissues. This involved breeding S100A4-Cre mice to ROSA26-lacZ mice and infusing the progeny with either saline or Ang II for 28 days. At termination, ascending and descending aortas were harvested and serial sections were stained for β-gal. Nuclei positive for β-gal were counted in both ascending and descending aortic regions ( Figure IIIA in the online-only Data Supplement). Nuclei counts increased significantly after Ang II infusion compared with saline infusion in the ascending region (P<0.05; Figure 5A ). In saline-infused mice, S100A4-lacZ expression was detected sparsely in the media and adventitia of ascending and descending aortas ( Figure 5B ). However, after 28 days of Ang II infusion, S100A4-lacZ expression increased as more positive staining nuclei were detected in adventitial and medial layers of ascending aortas ( Figure 5B ). In contrast, there was no change in S100A4-lacZ positive cell numbers present in descending aortas during Ang II infusion ( Figure 5B ).
We further examined β-gal positive nuclei counts in the 3 layers of the aorta, such as intima, media, and adventitia ( Figure 6A ). The results demonstrated that nuclei positive for β-gal were increased significantly in the adventitial and medial layers after 28 days of Ang II infusion only in the ascending aortic region ( Figure 6A ; Figure III online-only Data Supplement). However, there was no change in the number of nuclei positive for β-gal in the descending region ( Figure 6A ). Throughout the aortic media, nuclei positive for β-gal were also positive for α-actin ( Figure 6B ). Serial sections of saline or Ang II-infused ascending aortas were examined for cell types and mesenchymal phenotype. As expected, medial SMCs stained positive for α-actin. Fibroblast immunostaining for reticular subtypes with ER-TR7, were more abundant in adventitia of Ang II-infused aortas compared with saline-infused aortas. Although immunostaining for S100A4 yielded diffuse positive areas across the Ang II-infused aorta. Mesenchymal phenotypic staining for vimentin was predominant in all cell types of the ascending aorta of Ang II-infused mice ( Figure IV in the online-only Data Supplement).
Discussion
Ang II infusion into mice promotes uniform aortic medial thickening attributable to expansion of either the number or size of SMCs in a region-specific manner. 3 Several studies have demonstrated that Ang II-induced medial expansion is because of stimulation of AT1 receptors. 3, 5 In rodents, the AT1a subtype mediates these effects. 3, 5 The AT1 receptor expressing cell type responsible for this hypertrophy has not been defined and was the basis for the present studies that generated AT1a receptor deficiencies in smooth muscle, endothelial, neural, and fibroblasts cells. Using these mice with cell-specific deletion of AT1a receptors, this study demonstrated that Ang II stimulation of AT1a receptors in fibroblasts plays a critical role in medial thickening of the ascending aorta.
Ang II-induced medial thickening is due primarily to increased distance between elastin layers with cells that immunostain for SMC markers. 3, 5 Also, cultured SMCs respond to Ang II with hypertrophic and hyperplastic responses via AT1 receptor stimulation. 1, 8 Therefore, deletion of AT1a receptors in SMCs would be expected to attenuate medial thickening in vivo. Despite this expectation, previous studies demonstrated that AT1a receptor deletion from SMCs had no effect on medial thickening or blood pressure changes in response to Ang II . Fibroblast cell-specific angiotensin II (Ang II) type 1a (AT1a) receptor deficiency decreased Ang II-induced medial hyperplasia in the ascending aorta. A, Abundance of AT1a receptor mRNA in aortic adventitia of AT1a receptor floxed S100A4-Cre 0/0 (n=3) and S100A4-Cre +/0 (n=3) mice. Histobars with error bars represent mean±SEM. *P<0.05 in comparing S100A4-Cre 0/0 vs S100A4-Cre +/0 mice by Student t test.
Medial thickness was measured in ascending (B) and descending (C) aortas from AT1a receptor floxed S100A4-Cre 0/0 and S100A4-Cre +/0 mice infused with either saline (n=4-6 in each genotype) or Ang II (n=8-10 in each genotype). Histobars with error bars are mean±SEMs. *P<0.05 when comparing saline vs Ang II and #P<0.05 when comparing S100A4-Cre 0/0 versus S100A4-Cre +/0 in Ang II-infused groups by 2-way ANOVA with Holm-Sidak post hoc test. Nuclei density represented by normalization to aortic section length (0.25 mm) in ascending (D) and descending (E) sections from AT1a receptor floxed S100A4-Cre 0/0 and S100A4-Cre +/0 mice infused with either saline (n=3 in each genotype) or Ang II (n=5 in each genotype). Histobars with error bars represent mean±SEMs. *P<0.05 when comparing saline vs Ang II within Cre genotype and #P<0.05 when comparing S100A4-Cre 0/0 versus S100A4-Cre +/0 in Ang II-infused groups of the ascending aortic by 2-way ANOVA with Holm-Sidak post hoc test. F, Representative photomicrographs of ascending and descending aortas stained with propidium iodide from AT1a receptor S100A4-Cre 0/0 and S100A4-Cre +/0 mice infused with Ang II.
infusion. 5, 13 This was confirmed in this study. Although AT1a receptor mRNA is present in mouse aortic SMCs, its function is unclear. 3 Ex vivo, mouse aortic rings do not contract to Ang II, except for the infrarenal region. 12, 15, 16 Aortic tissue also expresses AT1b receptors, but deletion of this subtype had no effect on Ang II-induced aortic pathology. 11 Therefore, there has been consistent observations in the restricted responses of mouse aortic SMCs in vivo to Ang II. The negative effects are also potentially attributable to incomplete deletion of AT1a receptors. We were unable to determine the deletion of the AT1 receptor protein because of limitations of available antibodies. 12, 17, 18 However, previous studies have demonstrated the highly efficient deletion of genes including AT1a receptors 3, 5 using the SM22-Cre promoter. 19 Hence, the collective data are consistent with aortic medial thickening not being attributable to a direct effect of Ang II on SMCs. Endothelial cells also express AT1a receptors and release potential mediators that can influence changes in SMC function, including adversely regulating nitric oxide and oxygen radical availability. 20 However, depletion of AT1a receptors had no effect on blood pressure, as described previously. 12, 13 We have demonstrated previously that deletion of AT1a receptors in endothelial cells had a modest effect on reducing Ang II-induced expansion of aortic arches and maximal medial thickness in hypercholesterolemic mice. 12 The ability to discern effects of endothelial-specific AT1a receptor depletion in these earlier studies may be attributable to hypercholesterolemia-induced augmentation of Ang II responses in AT1a receptor wild-type mice. 21, 22 However, in this study, endothelial-specific depletion of AT1a receptors had no discernable effect on Ang II-induced medial expansion.
Because deletion of AT1a receptors on 2 major cell types in aortic intimal and medial tissue showed no effect on Ang II-induced blood pressure changes, other cell types were investigated. This included neuronal cells that exert a pivotal role in the renin-angiotensin system and blood pressure regulation. 23 A previous study showed that mice with AT1a receptor overexpression, under control of an Eno2 promoter, had enhanced responses to intracerebroventricularly injected Ang II. 24 Our studies used an Eno2 regulated Cre to delete AT1a receptors in neuronal cells and we were unable to discern an effect on blood pressure responses during peripheral administration of Ang II. Despite this lack of effect on blood pressure, there was a pronounced reduction in Ang II-induced medial thickening in the ascending aorta. One potential interpretation of this result is that the Eno2 promoter could delete AT1a receptors in cell types other than neurons. Expression of the Eno2 promoter has been demonstrated not only in many regions of the brain but also in peripheral tissues. 25 In our own studies, there was a striking presence of Eno2 lineage-tracked cells in the adventitia of the ascending aorta, that colocalized with markers of reticular fibroblasts. This spatial expression was coincident with the region in which medial Ang II-induced thickening was attenuated in AT1a receptor floxed mice expressing Eno2 regulated Cre. These findings inferred that AT1a receptor expression in fibroblasts mediated some aspects of Ang II-induced medial thickening.
There is increasing awareness that adventitial cells exert a profound effect on the arterial wall. 26 This includes adventitial fibroblasts that are thought to contribute to aortic pathologies. [27] [28] [29] To determine the role of AT1a receptor expression on fibroblasts, we used mice expressing Cre under control of the S100A4 promoter. There is an increasing complexity to fibroblast phenotypes, 30 with S100A4 not being ubiquitously expressed in all subtypes. 31 Conversely, S100A4 promoter expression may also occur in other cell types, such as SMC, endothelium, and hematopoietic cells. [32] [33] [34] Therefore, the expression Cre under the control of the S100A4 promoter is unlikely to specifically delete AT1a receptor only in fibroblasts. However, this study failed to demonstrated any effect of deleting AT1a receptors in mice expressing Cre under the control of SM22, that expresses in SMCs, 14 and Tie2 that expresses in endothelial and hematopoietic cells. 35 Therefore, the use of multiple Cre transgenics enhances that likelihood that the observed phenotype was because of lack of AT1a receptor stimulation in a fibroblast-specific manner.
The mechanisms by which deletion of AT1a receptors in S100A4 expressing cells attenuated medial thickening in the ascending aortic media remain to be determined. Lineage tracking studies demonstrated that Ang II promoted a marked increase of S100A4 expressing cells in the media of the ascending aorta during Ang II infusion. Immunostaining for LacZ positive medial cells colocalized with the SMC marker, α actin, while being unstained by markers for reticular fibroblasts. One potential basis for the presence of lineage-tracked cells in the media is migration from the adventitia. Consistent with this proposal, several studies have provided evidence that fibroblasts migrate and acquire SMC-like phenotypes in the arterial wall in response to injury. 36 Alternatively, the increased presence of LacZ positive cells in the media may be a consequence of Ang II influencing phenotypic modulation that is a function of SMC plasticity. 37 Future studies will need to incorporate a broader range of approaches for manipulating fibroblast phenotype to determine the function of this cell type.
In summary, this study used multiple lines of mice with different cell-specific deletion of AT1a receptors to garner insight into mechanisms of Ang II-induced medial thickening. Results confirmed a previous study that delineated AT1a receptor expression on SMCs was not responsible for this pathological change. The pivotal finding that S100A4 expressing cells attenuated Ang II-induced medial expansion in the ascending aorta provides a stimulus for further study of fibroblast phenotypes in arterial pathology.
Sources of Funding
This study was funded by National Heart, Lung, and Blood Institute Grants HL107319 to A. Daugherty and American Heart Association Great Rivers Affiliate Post Doctoral Fellowships: 10POST3140016 and 12POST12030363 to A. Poduri.
